Hudson Bay Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-650,000
Closed -$6.86M – 1769
2026
Q1
$6.86M Hold
650,000
– – 0.02% 404
2025
Q4
$6.82M Hold
650,000
– – 0.02% 413
2025
Q3
$6.73M Hold
650,000
– – 0.02% 469
2025
Q2
$6.7M Hold
650,000
– – 0.02% 472
2025
Q1
$6.55M Buy
+650,000
New +$6.53M 0.02% 530

Other funds holding TDAC

Hudson Bay Capital Management's TDAC Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 650,000 shares — an estimated $6.86M sold.

Hudson Bay Capital Management first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $6.86M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 650,000 Translational Development Acquisition Corp shares in Q2 2026, an estimated $6.86M.
  • Hudson Bay Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • Hudson Bay Capital Management's Translational Development Acquisition Corp position peaked at $6.86M in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.